Bespoke Extracts (BSPK) Cash & Equivalents Growth (3y) (2014 - 2025)
Bespoke Extracts (BSPK) Cash & Equivalents Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 29.96% |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 20.41% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -2.73% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -2.02% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 3.22% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 52.71% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 36.93% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 10.41% |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 15.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 15.54% |
| Jun 30, 2025 | -61.86% |
| Mar 31, 2025 | -31.47% |
| Nov 30, 2021 | -61.95% |
| Aug 31, 2021 | -48.06% |
| May 31, 2021 | -35.90% |
| Feb 28, 2021 | 53.72% |
| Nov 30, 2020 | 24.25% |
| Aug 31, 2020 | 13.25% |
| May 31, 2020 | -87.60% |
| Feb 29, 2020 | 93.99% |
| Nov 30, 2019 | 118.58% |
| Aug 31, 2019 | 188.44% |
| May 31, 2019 | 198.35% |
| Feb 28, 2019 | 47.91% |
| Nov 30, 2018 | -2.90% |
| Aug 31, 2018 | -24.57% |
| May 31, 2018 | 10.11% |
| Feb 28, 2018 | -21.95% |
| Nov 30, 2017 | -29.61% |